As the 2016 Spring Season passaged into the summer, a new culture was seeded Upstream Manufacturing at Goodwin Biotechnology, as a 200L Single Use Bioreactor (SUB) and Alternating Tangential Flow (ATF) Perfusion System was added to our Upstream Operational capacity.

The Upstream Manufacturing Team from Goodwin and representatives from Repligen Corporation and GE Healthcare huddled to flip the switch and start the operations and training on the new Systems. Working together the system manufacturers provided familiarity and crossover with the Large Scale Stirred Tank Reactor (STR) systems that are currently in house.\

About the Author
David Cunningham
David is the Director of Corporate Development for Goodwin Bio and has been with the company for 9 years.